AU2000255628A1 - Formulation comprising thymol useful in the treatment of drug resistant bacterial infections - Google Patents

Formulation comprising thymol useful in the treatment of drug resistant bacterial infections

Info

Publication number
AU2000255628A1
AU2000255628A1 AU2000255628A AU5562800A AU2000255628A1 AU 2000255628 A1 AU2000255628 A1 AU 2000255628A1 AU 2000255628 A AU2000255628 A AU 2000255628A AU 5562800 A AU5562800 A AU 5562800A AU 2000255628 A1 AU2000255628 A1 AU 2000255628A1
Authority
AU
Australia
Prior art keywords
thymol
formulation
useful
treatment
bacterial infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000255628A
Inventor
Krishna Kumar Agarwal
Atique Ahmad
Mahendra Pandurang Darokar
Sunita Dhawan
Suman Preet Singh Khanuja
Sushil Kumar
Nirmal Kumar Patra
Dharmendra Saikia
Tiruppadiripuliyur Santha Kumar
Ajit Kumar Shasney
Prachi Sinha
Suchi Srivastava
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Publication of AU2000255628A1 publication Critical patent/AU2000255628A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
AU2000255628A 2000-03-28 2000-03-28 Formulation comprising thymol useful in the treatment of drug resistant bacterial infections Abandoned AU2000255628A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/536,124 US6514541B2 (en) 2000-03-28 2000-03-28 Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
PCT/IN2000/000033 WO2001072317A1 (en) 2000-03-28 2000-03-28 Formulation comprising thymol useful in the treatment of drug resistant bacterial infections

Publications (1)

Publication Number Publication Date
AU2000255628A1 true AU2000255628A1 (en) 2001-10-08

Family

ID=26324096

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000255628A Abandoned AU2000255628A1 (en) 2000-03-28 2000-03-28 Formulation comprising thymol useful in the treatment of drug resistant bacterial infections

Country Status (3)

Country Link
US (1) US6514541B2 (en)
AU (1) AU2000255628A1 (en)
WO (1) WO2001072317A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20010635A1 (en) 1999-10-08 2001-08-15 Smithkline Beecham Corp USEFUL FAB I INHIBITORS FOR THE TREATMENT OF BACTERIAL INFECTIONS
ES2320984T3 (en) * 2001-04-06 2009-06-01 Affinium Pharmaceuticals, Inc. FAB INHIBITORS I.
AU2002353383A1 (en) * 2002-03-28 2003-10-13 Council Of Scientific And Industrial Research Cleaning and desinfecting herbal compositions and their preparation
ES2518316T3 (en) 2002-12-06 2014-11-05 Debiopharm International Sa Heterocyclic compounds, their manufacturing methods and their use in therapy
CA2519429C (en) 2003-03-17 2013-08-06 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
US20050013882A1 (en) * 2003-04-16 2005-01-20 Jacques Owen Phyto fluid
ES2515101T3 (en) 2004-06-04 2014-10-29 Debiopharm International Sa Acrylamide derivatives as antibiotic agents
US7517541B2 (en) 2005-01-18 2009-04-14 A.M. Todd Company Oral care compositions derived from the Labiatae family
KR20080075027A (en) * 2005-12-05 2008-08-13 아피늄 파마슈티컬스, 인크. Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
EP2054422B1 (en) 2006-07-20 2017-06-14 Debiopharm International SA Acrylamide derivatives as fab i inhibitors
US8263613B2 (en) * 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
WO2009049900A1 (en) * 2007-10-18 2009-04-23 Dsm Ip Assets B.V. Novel nutraceutical compositions containing thymol and/or p-cymene or plant extracts for cognition
FR2925334A1 (en) * 2007-12-21 2009-06-26 Ceva Sante Animale Sa NEW ANTIBACTERIAL COMPOSITIONS
WO2010009572A1 (en) * 2008-07-23 2010-01-28 国防教育研究基金会 New low side effect pharmaceutical composition containing isoniazid
NZ702695A (en) 2012-06-19 2015-10-30 Debiopharm Int Sa Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
US10751351B2 (en) 2016-02-26 2020-08-25 Debiopharm International S.A. Medicament for treatment of diabetic foot infections
EP3793511A1 (en) 2018-05-18 2021-03-24 Kancor Ingredients Ltd Anti-dandruff composition

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2035267A (en) 1934-02-10 1936-03-24 Louis Schumacher Effervescent sodium perborate
US2094671A (en) 1936-04-04 1937-10-05 Poetschke Paul Composition of matter suitable for a dentifrice
US3518343A (en) 1967-10-02 1970-06-30 Miles Lab Effervescent tablet and process for making same
US3821117A (en) 1971-07-23 1974-06-28 Carter Wallace Effervescent tablet
US3936385A (en) 1973-08-09 1976-02-03 Colgate-Palmolive Company Denture cleanser
US4307109A (en) 1980-05-08 1981-12-22 Abbott Laboratories Biocidal chelate
US4383986A (en) 1981-08-17 1983-05-17 Ortho Pharmaceutical Corporation Hemorrhoidal compositions
US4863725A (en) 1982-10-27 1989-09-05 Deckner George E Novel clear oil-free moisturizer composition
CH643138A5 (en) 1983-08-29 1984-05-30 Mepha Ag INDOMETHACIN CONTAINING, gelatinous OINTMENT.
US4702916A (en) 1985-12-03 1987-10-27 Warner-Lambert Company Analgesic stick compositions
JPS62252718A (en) * 1986-04-24 1987-11-04 Nitto Electric Ind Co Ltd Deodorized chemical
DE3704907A1 (en) 1987-02-17 1988-08-25 Bayer Ag TOPICALLY APPLICABLE PREPARATIONS OF GYRASE INHIBITORS IN COMBINATION WITH CORTICOSTEROIDS
US4847071A (en) 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
US4925655A (en) 1988-03-04 1990-05-15 Robell Research Powder composition for forming a mouthwash
US5073366A (en) 1989-05-30 1991-12-17 Fred Beck Analgesic composition useful in providing a temporary relief from symptoms of arthritis
US5801153A (en) 1991-09-13 1998-09-01 Badaway; Mohammed A. Method of enhancing the antimicrobial properties of antibacterial antibiotics to massively control and prevent bacterial, fungal, and viral diseases in plants
US5411733A (en) 1992-04-27 1995-05-02 Hozumi; Toyoharu Antiviral agent containing crude drug
US5529778A (en) 1994-09-13 1996-06-25 Rohatgi; Surendra Ayurvedic composition for the prophylaxis and treatment of AIDS, flu, TB and other immuno-deficiencies and the process for preparing the same
US5980903A (en) 1997-08-27 1999-11-09 Pruthi; Som C. Composition for the treatment of viral infections including HIV
USPP12030P2 (en) * 1998-06-03 2001-08-07 Council Of Scientific And Industrial Research Hybrid mint plant named ‘Neerkalka’
US6127405A (en) * 1998-07-10 2000-10-03 Council Of Scientific And Industrial Research Method for the use of alpha arteether as an anti-bacterial and anti-fungal agent

Also Published As

Publication number Publication date
US20020090380A1 (en) 2002-07-11
US6514541B2 (en) 2003-02-04
WO2001072317A1 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
AU2002213357A1 (en) Variant igg3 rituxan r and therapeutic use thereof
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
AU2001279905A2 (en) Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents
AU2001279905A1 (en) Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
AU2001277741A1 (en) 2-aminopyridine compounds and use thereof as drugs
AU5982300A (en) Novel methods and medicament for treating infectious diseases involving microbial biofilms
AU2002239397A1 (en) Drug formulation having improved oral tolerability
AU2001280188A1 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU2003901008A0 (en) Composition for the treatment and prevention of bacterial infections
AU2002354476A1 (en) Pyrazolopyridine derivatives and medicinal use thereof
AU1164601A (en) Therapeutic use and formulation
AUPQ879500A0 (en) Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
AUPQ344799A0 (en) Treatment of respiratory diseases and infections
WO2002000208A3 (en) Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined with specific pharmaceutical active agents
AU5842300A (en) Pharmaceutical composition useful for the treatment of tinnitus and hearing loss
AU2002314331A1 (en) Bacteriophage preparation for the treatment of intracellular bacterial infection
WO2002057281A3 (en) Aminoglycosides as antibiotics
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
AU2001262928A1 (en) Pharmaceutical compositions and their use
AU2002220584A1 (en) Use of lipopeptides or lipoproteins for treating lung infections and lung tumours
AU2001267177A1 (en) Diagnosis and treatment of herpes infections
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii
AU2001292500A1 (en) 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain